molecular glue degrader
A molecular glue degrader is a small molecule that destroys a disease protein by sticking it to the cell's protein-disposal machinery. Like the larger two-headed degraders, it ends with the target being shredded — but instead of having one arm for the target and one for the disposal enzyme, a molecular glue is a single compact molecule that simply makes two proteins suddenly want to hold hands.
The mechanism is a piece of induced matchmaking. The glue tucks into the surface of an E3 ubiquitin ligase, the cell's labeling enzyme, and subtly reshapes it so that it now recognizes a target protein it would normally ignore. The ligase then tags that newly invited target with ubiquitin, marking it for the proteasome to chew up. Strikingly, the target itself may have no real pocket for a drug; the glue creates the interaction surface that drags it to its doom.
The appeal is huge: molecular glues are small, drug-like, often orally available, and can take down proteins long deemed undruggable. The difficulty is that they are hard to design on purpose — many were found by luck — because predicting which small molecule will glue which two proteins together remains a frontier challenge.
Lenalidomide and related drugs glue the E3 ligase cereblon to transcription factors such as IKZF1, redirecting the cell to degrade them and killing certain blood cancers.
A molecular glue redirecting an E3 ligase to degrade a transcription factor.
Molecular glue degraders and PROTACs both end in proteasomal destruction, but a glue is a single small molecule that reshapes a protein surface, whereas a PROTAC is a larger bifunctional molecule with two distinct binding arms.